May 28, 2024, 08:31
Gilberto Lopes: Press release just in time to make things more interesting for ASCO24
Gilberto Lopes, Chief of the Division of Medical Oncology at Sylvester Comprehensive Cancer Center, shared a post on X:
”Press release just in time to make things more interesting for ASCO24 – Datopotamab deruxtecan showed ‘clinically meaningful’ overall survival improvement vs. chemotherapy in patients with advanced nonsquamous non-small cell lung cancer in TROPION-Lung01 Phase III trial.”
Read further.
Source: Gilberto Lopes/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 15, 2024, 07:51
Nov 15, 2024, 07:46
Nov 15, 2024, 07:05
Nov 15, 2024, 07:03
Nov 15, 2024, 06:33